PAI
Palo Alto Investors Portfolio holdings
AUM $470M
1-Year Return
2.57%
This Quarter Return
+10.42%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.14B
AUM Growth
+$26.3M
(+1.2%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
40
New
1
Increased
15
Reduced
4
Closed
2
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$26.6M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$13.7M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$4.27M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
+$2.39M |
| 5 |
Insmed
INSM
|
+$1.5M |
Top Sells
| 1 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$113M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$52.9M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
+$5.49M |
| 4 |
United Therapeutics
UTHR
|
+$2.08M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$1.09M |
Sector Composition
| 1 | Healthcare | 94.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $312M | 14.55% |
3,329,581
-565,382
| -15% | -$52.9M |
|
|
ABMD
2
DELISTED
Abiomed Inc
ABMD
| $280M | 13.05% |
1,951,284
+29,800
| +2% | +$4.27M |
|
|
3
United Therapeutics
UTHR
$18B
| $242M | 11.31% |
1,867,315
-16,000
| -0.8% | -$2.08M |
|
4
BioMarin Pharmaceuticals
BMRN
$10.2B
| $217M | 10.11% |
2,384,719
+2,100
| +0.1% | +$191K |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $125M | 5.86% |
1,030,942
+3,882
| +0.4% | +$472K |
|
|
6
Insmed
INSM
$30.3B
| $96.5M | 4.5% |
5,621,816
+87,666
| +2% | +$1.5M |
|
|
EPZM
7
DELISTED
Epizyme, Inc
EPZM
| $86M | 4.02% |
5,698,296
+907,245
| +19% | +$13.7M |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $82.3M | 3.84% |
1,033,025
-68,926
| -6% | -$5.49M |
|
9
Amicus Therapeutics
FOLD
$2.38B
| $80M | 3.73% |
7,940,788
+57,800
| +0.7% | +$582K |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $73.6M | 3.43% |
2,676,393
+48,200
| +2% | +$1.33M |
|
11
Vanda Pharmaceuticals
VNDA
$259M
| $68.5M | 3.2% |
4,203,270
| – | – |
|
|
AMAG
12
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $61.5M | 2.87% |
3,344,620
| – | – |
|
13
Prothena Corp
PRTA
$439M
| $58.1M | 2.71% |
1,073,955
+18,100
| +2% | +$980K |
|
14
Acadia Pharmaceuticals
ACAD
$4.16B
| $45M | 2.1% |
1,613,330
+22,900
| +1% | +$639K |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $38.3M | 1.79% |
295,240
| – | – |
|
16
STAAR Surgical
STAA
$1.37B
| $38.1M | 1.78% |
3,529,070
+55,900
| +2% | +$604K |
|
17
Align Technology
ALGN
$9.5B
| $33.5M | 1.56% |
223,107
| – | – |
|
18
Karyopharm Therapeutics
KPTI
$54.3M
| $31.4M | 1.47% |
231,172
+4,074
| +2% | +$553K |
|
|
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $30.2M | 1.41% |
1,787,576
+28,200
| +2% | +$477K |
|
|
IMMU
20
DELISTED
Immunomedics Inc
IMMU
| $26.6M | 1.24% |
+3,010,466
| New | +$26.6M |
|
|
AIMT
21
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $26.5M | 1.24% |
1,289,719
+116,221
| +10% | +$2.39M |
|
22
Gilead Sciences
GILD
$140B
| $24.9M | 1.16% |
351,600
| – | – |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $21.5M | 1% |
130,200
| – | – |
|
24
Exact Sciences
EXAS
$10.1B
| $15.3M | 0.72% |
433,076
+7,800
| +2% | +$276K |
|
|
25
Rigel Pharmaceuticals
RIGL
$669M
| $10.5M | 0.49% |
385,502
-39,960
| -9% | -$1.09M |
|